Review
Copyright ©2009 Baishideng. All rights reserved.
World J Hepatol. Oct 31, 2009; 1(1): 72-78
Published online Oct 31, 2009. doi: 10.4254/wjh.v1.i1.72
Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms
Luis A Videla
Luis A Videla, Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago-7, Chile
Author contributions: Videla LA solely contributed to this paper.
Supported by Grant 1090020 From FONDECYT, Chile
Correspondence to: Luis A Videla, Professor, Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago-7, Chile. lvidela@med.uchile.cl
Telephone: +56-2-9786256 Fax: +56-2-7372783
Received: July 20, 2009
Revised: September 10, 2009
Accepted: September 17, 2009
Published online: October 31, 2009
Abstract

Oxidative stress is a redox imbalance between pro-oxidants and antioxidants in favour of the former ones, leading to different responses depending on the level of pro-oxidants and the duration of the exposure. In this article, we discuss the damaging or cytoprotective signaling mechanisms associated with oxidative stress by addressing (1) the role of prolonged and severe oxidative stress and insulin resistance as determinant factors in the pathogenesis of non-alcoholic fatty liver disease associated with obesity, which, with the concurrence of nutritional factors, may determine the onset of fatty liver and its progression to steatohepatitis; and (2) the development of an acute and mild pro-oxidant state by thyroid hormone administration, which elicits the redox up-regulation of the expression of proteins affording cell protection, as a preconditioning strategy against ischemia-reperfusion liver injury.

Keywords: Oxidative stress, Obesity, Insulin resistance, Non-alcoholic fatty liver disease, Thyroid hormone, Liver preconditioning